Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
KIRKLAND, QC, March 5, 2024 /CNW/ - As part of our commitment to embedding diversity, equity, and inclusion into our business, Merck Canada is continually exploring ways to give back to the...
Approval is based on the Phase 3 KEYNOTE-811 Trial KIRKLAND, QC, Feb. 12, 2024 /CNW/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that Health Canada has granted...
KIRKLAND, QC, Feb. 8, 2024 /CNW/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, has entered into a multi-year agreement with the Vector Institute in Toronto, an independent...
KIRKLAND, QC, and MISSISSAUGA, ON, Dec. 21, 2023 /CNW/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai announce that KEYTRUDA®, Merck's anti-PD-1 therapy, plus...
'Be the MVP' campaign aims to change the odds on lung cancer in Canada KIRKLAND, QC, Nov. 1, 2023 /CNW/ - This month, Hayley Wickenheiser and Merck Canada are teaming up to challenge all Canadians to ...
KIRKLAND, QC, and MISSISSAUGA, ON, Oct. 25, 2023 /CNW/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai announced today that KEYTRUDA®, an anti-PD-1 therapy, in...
GARDASIL®9 is the first vaccine in Canada approved for the prevention of HPV-Related Oropharyngeal and other Head and Neck Cancers caused by HPV types 16, 18, 31, 33, 45, 52, and 58 KIRKLAND, QC,...
Molnupiravir will be manufactured at Thermo Fisher Scientific's site in Whitby, ON KIRKLAND, QC, Dec. 6, 2021 /CNW/ - Merck (NYSE: MRK), known as MSD outside Canada and the United States, announced...
TORONTO, Dec. 4, 2021 - /CNW/ - Members of the media are invited to attend an important event regarding a biomanufacturing announcement to help address the fight against COVID-19. Government...
KIRKLAND, QC, Dec. 3, 2021 /CNW/ - Merck (NYSE: MRK), known as MSD outside Canada and the United States, announced today that it has entered into a Supply Agreement with the Government of Canada for...
KIRKLAND, QC, Aug. 13, 2021 /CNW/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the initiation of a rolling submission to Health Canada for molnupiravir, an...
With approximately 300 Quebec women, between 25 and 44 years, diagnosed with cervical cancer each year, Olympic medalist and World Champion Marianne St-Gelais asks women to take their health into...
KIRKLAND, QC, May 27, 2019 /CNW/ - Today, the Government of British Columbia announced its Biosimilars Initiative, which will transition patients who use specific reference biologic drugs for some...
KIRKLAND, QC, Sept. 11, 2018 /CNW Telbec/ - Merck Canada Inc., known as MSD outside Canada and the United States, notified health care professionals of important information on MARVELON® 28...
• Ivermectin, a treatment for potentially devastating tropical parasitic infections, and the subject of a Nobel Prize, is on the World Health Organization's List of Essential Medicines1,2 • The...
RENFLEXIS™ has been added to drug formulary for the treatment of adult and pediatric Crohn's disease and ulcerative colitis, as well as for the treatment of fistulising Crohn's disease, rheumatoid...
KIRKLAND, QC, Dec. 14, 2017 /CNW Telbec/ - Merck & Co., Inc. (NYSE: MRK), known as MSD outside Canada and the United States, announced today that the recently approved PREVYMIS™ (letermovir) is...
KIRKLAND, QC, Oct. 31, 2017 /CNW Telbec/ - On October 30th, Merck Canada Inc.'s President Chirfi Guindo presented a cheque totalling more than $125,000 for the International Neighbour of Choice award ...
On average, 78 Canadians will be diagnosed with lung cancer every day1 Non-small cell lung cancer is the most common form of lung cancer, making up 80 to 85% of all cases2 The five-year relative...
The number of people living with HIV in Canada (prevalence) is increasing1 An estimated 75,500 Canadians were living with HIV at the end of 20141 This represents an increase of 6,700 people (9.7%)...
TORONTO, May 25, 2017 /CNW Telbec/ - A unique Indigenous-led, community-hospital-university-private sector partnership to enhance Indigenous maternal and child health will address some of the...
TORONTO, May 19, 2017 /CNW Telbec/ - Media are invited to the Native Canadian Centre of Toronto (NCCT) for the launch of an innovative new project, Kind Faces, Sharing Places: An Action Research...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.